Optimalab INC

Optimalab INC was paid $20.42M by Medicaid between Nov 2018 and Aug 2024, across 52 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 72% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Illinois

Rank by total paid#9 of 235

Median peer was paid$123K

This provider vs. median166×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	66	$0.00
2019	2,855	$2K
2020	40,025	$2.30M
2021	167,512	$6.43M
2022	270,476	$9.50M
2023	61,559	$2.14M
2024incomplete	5,527	$47K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	72%	235,041	67,360	$14.71M
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	17%	185,461	55,067	$3.53M
G2024	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source	9.7%	98,138	26,634	$1.98M
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	2,656	1,163	$49K
84443	Thyroid stimulating hormone (TSH)	<1%	2,222	1,853	$26K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	2,186	1,826	$19K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	422	324	$17K
82607		<1%	1,274	1,018	$12K
83036	Hemoglobin; glycosylated (A1C)	<1%	1,934	1,625	$9K
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	<1%	152	116	$9K
P9604	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge	<1%	1,720	1,072	$8K
82746		<1%	604	459	$6K

40 more codes

84439		<1%	689	$5K
82172		<1%	417	$5K
80053	Comprehensive metabolic panel	<1%	1,055	$4K
87086	Culture, bacterial; quantitative colony count, urine	<1%	753	$3K
82728		<1%	401	$3K
83540		<1%	410	$3K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	1,132	$3K
86803		<1%	168	$2K
80061	Lipid panel	<1%	591	$2K
84481		<1%	187	$2K
83735		<1%	430	$2K
83880		<1%	259	$2K
84153		<1%	125	$1K
86769		<1%	37	$1K
87186		<1%	379	$1K
87088		<1%	374	$1K
99072		<1%	2,617	$972.96
86141		<1%	59	$715.32
85651		<1%	186	$689.54
82043		<1%	192	$631.49
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	15	$617.99
82150		<1%	105	$580.78
83690		<1%	76	$444.92
36415	Collection of venous blood by venipuncture	<1%	3,177	$444.77
84480		<1%	50	$395.10
84466		<1%	57	$379.99
84100		<1%	139	$322.23
84550		<1%	111	$262.10
82947		<1%	75	$235.96
83090		<1%	17	$202.65
86140		<1%	57	$198.55
84520		<1%	54	$172.46
82570		<1%	42	$169.45
82550		<1%	31	$157.13
86376		<1%	17	$122.02
81001		<1%	104	$115.39
85652		<1%	45	$60.19
87077		<1%	290	$16.50
81003		<1%	167	$3.60
P9603	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled	0%	1,120	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialAKHTER, REHAN (MANAGER)